Omicron coronavirus variant is now in the USA
The CDC has confirmed the first case of Omicron Coronavirus variant in the USA, it was detected in California, and the stock market sold off to this news. A traveler who returned from South Africa on ...
The CDC has confirmed the first case of Omicron Coronavirus variant in the USA, it was detected in California, and the stock market sold off to this news. A traveler who returned from South Africa on ...
The safety group of the CDC has revealed the likelihood of an association between a rare heart inflammatory condition in adolescents and young adults after they’ve received their second Covid-19 vac...
India’s number of daily coronavirus deaths has reached over 6,000 after a single state revised its data for fatalities during the second wave, raising fears that the country’s toll is much higher ...
Amid vaccine scarcity on the continent, it has been reported that thousands of vaccine doses are set to be destroyed in African countries because they've exceeded their expiry dates.Others are simply ...
India’s population is 1.4 billion and this means they are at a very high risk of covid related casualties due to how fast the disease can spread. Covid started from China, then it hit th...
The U.S. Centers for Disease Control (CDC) is probing Johnson & Johnson for the death of an Oregon woman and hospitalization of a patient in Texas over the use of its COVID-19 vaccines, state offi...
The use of the Johnson and Johnson's vaccine has been temporarily stopped by the Food and Drug Administration. This order by the FDA was given to states after it was discovered that six women develope...
Transnational Corporation of Nigeria Plc. (Transcorp) – Nigeria’s leading diversified conglomerate – has released officially released its audited financial statements for the year ended De...
International Monetary Fund (IMF), in a report issued April 5, 2021, identified several factors that could affect the economic recovery of low-income and developing countries from the impact of Covid-...
VLP Therapeutics, a US-based biopharmaceutical company founded in 2013, announced on Monday that it has secured Series A funding worth $16 million from investors such as MIYAKO Capital and Konishiyasu...